Search for other papers by Konstantin Yakimchuk in
Google Scholar
PubMed
Search for other papers by Chandrashekar Bangalore Revanna in
Google Scholar
PubMed
Search for other papers by Dan Huang in
Google Scholar
PubMed
Search for other papers by Jose Inzunza in
Google Scholar
PubMed
Search for other papers by Sam Okret in
Google Scholar
PubMed
line with our results, genistein was suggested to have a chemotherapy-potentiating effect by enhancing the anti-proliferative activity of a combination of cytostatic drugs on DLBCL cells in vitro and in a xenograft mouse model of DLBCL ( 34 ). These
Search for other papers by Jiwen Yang in
Google Scholar
PubMed
Search for other papers by Yayin Huang in
Google Scholar
PubMed
Search for other papers by Bohan Dong in
Google Scholar
PubMed
Search for other papers by Yunhai Dai in
Google Scholar
PubMed
TNFAIP8 3’ UTR was constructed into the reporter vector. The validation of the combination between TNFAIP8 and miR-205-5p was conducted following the same approach. Murine xenograft assay Nude mice purchased from Beijing Vital River Laboratory
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Satoshi Inoue in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Taichi Mizushima in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Hiroki Ide in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Guiyang Jiang in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Takuro Goto in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Yujiro Nagata in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Search for other papers by George J Netto in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Hiroshi Miyamoto in
Google Scholar
PubMed
’s correlation coefficient (CC). The rates of xenograft tumor formation and patient survival were calculated by the Kaplan–Meier method and comparison was made by log-rank test. The Cox proportional hazards model was used to determine statistical significance of
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
mm silicon ring on the surface of the chorioallantoic membrane (CAM). Xenografts were treated topically every day, either with 2.2 µM shikonin (2 × IC 50 ) in 10 μL PBS ( n = 9) or with 0.02% DMSO in PBS ( n = 12) for 3 days. On day 4 after seeding
Search for other papers by Jan-Bernd Stukenborg in
Google Scholar
PubMed
Division of Haematology-Oncology and Stem Cell Transplantation, Children’s Hospital, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Search for other papers by Kirsi Jahnukainen in
Google Scholar
PubMed
Search for other papers by Marsida Hutka in
Google Scholar
PubMed
Edinburgh Royal Hospital for Sick Children, Edinburgh, UK
Search for other papers by Rod T Mitchell in
Google Scholar
PubMed
( 71 ). In this study, testis tissue was xenografted into immunocompromised host mice. Smooth muscle actin (SMA; a functional marker of PTM cells) expression in non-irradiated tissues was reported to appear following the 6.5 months of xenografting
Search for other papers by Serena Martinelli in
Google Scholar
PubMed
Search for other papers by Mario Maggi in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
subcutaneously into NOD scid gamma (NSG) mice by using a previously described protocol ( 46 ). To generate primary cell cultures, minced xenograft tissue was dissociated in collagenase followed by trypsin ( 30 ). The utilisation of xenografts to develop cell
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Christina Angelika Passegger in
Google Scholar
PubMed
Search for other papers by Laura Nebel in
Google Scholar
PubMed
Search for other papers by Fabian Krismer in
Google Scholar
PubMed
Search for other papers by Gudrun Herzer-Schneidhofer in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
. Written informed consent was obtained from all patients. The study was approved by the Ethical Committee of the Medical University of Graz (# 18-182 ex 06/07). CAM xenografts We performed the ex ovo CAM method according to Deryugina et al . ( 15
Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Search for other papers by Jennifer Lo in
Google Scholar
PubMed
Search for other papers by Natasha Ascui in
Google Scholar
PubMed
Search for other papers by Matthew J Watt in
Google Scholar
PubMed
associated metabolic and endocrine co-morbidities including increased visceral adipose tissue deposition, glucose intolerance, mild hyperinsulinemia, dyslipidemia and subclinical inflammation. Xenograft studies that involve subcutaneous injection of
Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Naples, Italy
Search for other papers by Maria Cristina De Martino in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Claudia Pivonello in
Google Scholar
PubMed
Search for other papers by Chiara Simeoli in
Google Scholar
PubMed
Search for other papers by Fortuna Papa in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
, the inhibition of NCI-H295R xenograft growth has been reported using high everolimus dose ( 29 ). Additionally, sirolimus was found to significantly reduce cell survival and cortisol secretion only in selected ACC primary cultures ( 28 ). These data
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
line-derived xenograft (PC-3, DU145) growth in intact and degarelix-suppressed nude mice ( 8 ). In humans, a crossover study from agonist (leuprolide) to antagonist (degarelix) demonstrated better prostate cancer control with the latter, with a